Clostridium butyricum in combination with specific immunotherapy converts antigen-specific B cells to regulatory B cells in asthmatic patients

• DOI: 10.1038/srep20481
• Publication Date: 2016-02-09T10:33:08Z
• Authors: Hong-Ying Liao; Li Tao; Jian Zhao; Jie Qin; Gu-Cheng Zeng; Song-Wang Cai; Yun Li; Jian Zhang; Hui-Guo Chen
• Keywords: Male; STAT3 Transcription Factor; B-Lymphocytes, Regulatory; 0303 health sciences; Immunoglobulin E; Article; Asthma; Arthropod Proteins; Interleukin-10; 3. Good health; Cysteine Endopeptidases; 03 medical and health sciences; Clostridium butyricum; Humans; Female; Antigens, Dermatophagoides; Immunotherapy; E1A-Associated p300 Protein

AbstractThe effect of antigen specific immunotherapy (SIT) on asthma is supposed to be improved. Published data indicate that administration of probiotics alleviates allergic diseases. B cells play important roles in the pathogenesis of allergic diseases. This study aims to modulate antigen specific B cell property by the administration of Clostridium butyrate (CB) in combination with SIT. The results showed that after a 3-month treatment, the total asthma clinical score and serum specific IgE were improved in the patients treated with SIT, which was further improved in those treated with both SIT and CB, but not in those treated with CB alone. Treatment with SIT and CB increased p300 and STAT3 activation, up regulated the IL-10 gene transcription and increased the frequency of peripheral antigen specific B cells. In conclusion, administration with SIT in combination with CB converts Der p 1 specific B cells to regulatory B cells in asthma patients allergic to Der p 1. The data suggest a potential therapeutic remedy in the treatment of allergic diseases.